Raydiax is on a mission to increase the quality of everyday minimally invasive interventions providing the world’s first therapy-assist CT system. Its imaging solutions enable safe, intuitive, and efficient procedures for patients and clinicians worldwide. Here are details of Raydiax‘s latest funding round :
🚀 Launch
2022 (March)
🏭 Industry
Medical Equipment Manufacturing
🧠Management
Thomas Hoffmann (CEO), Tim Pfeiffer (CTO), Roy Rothenberg (CFO), Robert Frysch (Head of Imaging Software), André Mewes (Head of Therapy Solutions), Benjamin Fritsch (Head of Hardware & Control)
💸 Funding & Investors
INVESTMENT (October 2023) | €3.5 million |
INVESTORS (October 2023) | €2.4m was led by HTGF and bmp Ventures with IBG funds. In addition, Raydiax will receive €1.1m in funding through a top-up of an “EXIST: transfer of research” grant from the German Federal Ministry for Economic Affairs and Climate Action (BMWK). |
🎯 Funding purpose
Advance the development of the preclinical prototype and prepare for market entry in Europe and the USA.
🌐 Country HQ
Germany (Magdeburg)